Farastuk Bozorgmehr - Dissemin

Language
Login

All papers authored by Farastuk Bozorgmehr

This paper is made freely available by the publisher.

2022 Farastuk Bozorgmehr

ORCID

, Petros Christopoulos, Inn Chung, Jelena Cvetkovic, Manuel Feißt, Johannes Krisam, Marc A. Schneider, Claus Peter Heußel, Michael Kreuter, Daniel W. Müller, Michael Thomas, Stefan Rieken

Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Petros Christopoulos

ORCID

, Klaus Kluck, Martina Kirchner

ORCID

, Heike Lüders, Julia Roeper, Roger-Fei Falkenstern-Ge, Marlen Szewczyk, Florian Sticht, Felix C. Saalfeld

ORCID

, Claas Wesseler

ORCID

, Björn Hackanson, Sebastian Dintner, Martin Faehling

ORCID

, Jonas Kuon, Melanie Janning and 22 other authors

The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions

Upload

This paper is made freely available by the publisher.

2020 Farastuk Bozorgmehr

ORCID

, Inn Chung, Petros Christopoulos

ORCID

, Johannes Krisam, Marc A. Schneider, Lena Brückner, Daniel Wilhelm Mueller, Michael Thomas, Stefan Rieken

Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

P. Christopoulos

ORCID

ORCID

, J. Roeper, F. Saalfeld, M. Janning

ORCID

, F. Bozorgmehr

ORCID

, N. Magios, D. Kazdal, A. L. Volckmar, L. M. Brückner, T. Bochtler, M. Kriegsmann, V. Endris, R. Penzel, K. Kriegsmann and 18 other authors

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Upload

This paper is made freely available by the publisher.

2019 Farastuk Bozorgmehr

ORCID

, Adriane Hommertgen, Johannes Krisam, Felix Lasitschka, Jonas Kuon, Martin Maenz, Peter E. Huber, Laila König, Meinhard Kieser, Juergen Debus, Michael Thomas, Stefan Rieken

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial

Download from doi.org

Missing publications? Search for publications with a matching author name.